Navigation Links
AstraZeneca and the Sacramento County Pharmacy Provide Free Medicines to Eligible California Patients

WILMINGTON, Del., Oct. 6 /PRNewswire/ -- AstraZeneca (NYSE: AZN) announced today that it is providing medicines at no cost to qualifying patients at the Primary Care Center Pharmacy in Sacramento, California.



AstraZeneca's partnership with the Sacramento County Pharmacy is an expansion of its AZ&Me™ Prescription Savings program that provides medicines at no cost to health facilities around the country. The Sacramento County Pharmacy is the ninth organization in California to join the program.

"The partnership with Sacramento County will help patients who might otherwise go without the medicines they need," said Jennifer McGovern, director, patient assistance programs, AstraZeneca Pharmaceuticals LP.

The Primary Care Center Pharmacy provides pharmaceuticals and medical supplies to nearly all departments within Sacramento County, dispensing an average of 1,200 prescriptions to patients per day.  Over the last eight years, the pharmacy's free drug programs have grown from one program with annual savings of $300,000 to 16 programs with annual savings in excess of $4.4 million. Approximately 25,000 uninsured patients benefit from the program.

"Working with AstraZeneca, the pharmacy will be able to get medicines to the people who need them, while focusing our resources on delivering programs and services to residents," said Steve Golka, director of pharmacy services, County of Sacramento.

Carrie's Touch, an organization that educates and empowers African-American women living with breast cancer in the Greater Sacramento area, praised the collaboration.

"I was fortunate enough to personally benefit from AZ&Me after losing my job and medical insurance," said Rev. Tammie Denyse, Carrie's Touch founder and president. "Without the support of this program, I would not have been able to receive my cancer medicine during this critical point in my treatment process. I am grateful this program exists."

Sacramento County Supervisor Roger Dickinson said, "AstraZeneca's commitment to providing free medicine is a crucial part of getting Sacramentans the care they need during tough economic times.  Many low-income workers don't have access to employer-sponsored health insurance and others lost coverage when they became unemployed during the recession.  Donated medicine ensures people get needed care and relieves financial pressure on an overburdened county health system."

In 2009, AstraZeneca provided more than $27.7 million in savings to more than 15,900 patients in California under its prescription savings programs – known as AZ&Me. Nationally, the company helped more than 507,000 patients save $769.6 million on their medicines.

About AZ&Me Prescription Savings Program for Healthcare Facilities

AZ&Me™ Prescription Savings program for healthcare facilities provides medicines free of charge to community free clinics, community health centers, hospitals and other qualifying facilities that serve the uninsured. The program is available to non-profit organizations that have a licensed outpatient pharmacy or dispensary on site and meet other program criteria. Patients are eligible for AstraZeneca medicines through this program if they do not have prescription drug coverage and have a household income at or below $30,000 for an individual or $60,000 for a family of four.

About AstraZeneca

AstraZeneca is a global, innovation-driven biopharmaceutical business with a primary focus on the discovery, development and commercialization of prescription medicines.  As a leader in gastrointestinal, cardiovascular, neuroscience, respiratory and inflammation, oncology and infectious disease medicines, AstraZeneca generated global revenues of $32.8 billion in 2009. In the United States, AstraZeneca is a $14.8 billion healthcare business.

For more information about AstraZeneca in the US or our AZ&Me™ Prescription Savings programs, please visit or call 1-800-AZandMe (292-6363). 

SOURCE AstraZeneca
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. AstraZeneca Joins Rochester Initiative to Further Cardiac Safety
2. AstraZeneca and Grace Hill Neighborhood Health Centers, Inc. Provide Medicines to Missouris Uninsured
3. Silence Therapeutics and AstraZeneca Extend siRNA Development Collaboration
4. FDA Updates U.S. Product Labels for LABA-Containing Medications Including AstraZenecas SYMBICORT
5. AstraZeneca to Support Drug-Induced Liver Injury Network at the National Institutes of Health
6. AstraZeneca Donates $1 Million for Christiana Care Health Systems Wilmington Hospital Project
7. Remarks as Prepared for Delivery By Attorney General Eric Holder at the AstraZeneca Settlement Announcement
8. Pharmaceutical Giant AstraZeneca to Pay $520 Million for Off-Label Drug Marketing
9. Palatin Technologies, Inc. Receives $2.5 Million from AstraZeneca
10. AstraZeneca Comments on FDA Joint Advisory Committee Meeting on Post-Marketing Safety Studies for the Use of LABAs in Asthma
11. AstraZeneca and Dako Sign Agreement to Develop Companion Diagnostics for Cancer Treatments
Post Your Comments:
(Date:12/1/2015)... , Dec. 2, 2015  A combination of detailed ... the first time in the surgical planning for separation of ... annual meeting of the Radiological Society of North ... --> Conjoined twins, or twins whose bodies are connected, ... rates are low and separating them through surgery is extremely ...
(Date:12/1/2015)... , Dec. 1, 2015  A large study ... drug tamoxifen while taking an antidepressant found no increased ... today in The Journal of the National Cancer Institute. ... Tamoxifen is a commonly prescribed generic drug taken by ... developing a recurrence. Tamoxifen is recommended for five years, ...
(Date:12/1/2015)... Wash. and VANCOUVER , ... Committee (DMC) meeting, OncoGenex Pharmaceuticals, Inc. (NASDAQ: OGXI ... is continuing based on the pre-planned interim futility analysis ... review, no new safety issues were identified by the ... all analyses and final results are expected in the ...
Breaking Medicine Technology:
(Date:12/1/2015)... ... December 01, 2015 , ... ... and hematology continuing medical education (CME), today announced that the first annual School ... New York. , “The prevention, detection and treatment of gastrointestinal cancers are undergoing ...
(Date:12/1/2015)... , ... December 01, 2015 , ... Growth in medical ... due to decreases in utilization of hospital and nonhospital care, according to a recent ... Medical Benchmarks for Louisiana, 16th Edition , found medical payments per claim with more ...
(Date:12/1/2015)... ... December 01, 2015 , ... ... images have been lifted as IMAGE Information Systems launches MED-TAB™ -- the world’s ... America Annual Meeting from November 29 to December 4, 2015. , MED-TAB ...
(Date:12/1/2015)... ... December 01, 2015 , ... ... Inc. (“Visage”), a wholly owned subsidiary of Pro Medicus Ltd. (ASX: PME), has ... the Radiological Society of North America (RSNA) 2015 annual meeting through December 3 ...
(Date:12/1/2015)... (PRWEB) , ... December 01, 2015 , ... ... clinical solutions for the care management and population health arenas, is pleased to ... clinical and cost containment services, has successfully implemented the ACUITY Complete Care™ Management ...
Breaking Medicine News(10 mins):